Cutaneous T-cell lymphoma and related skin lymphoma disorders
Kyowa Kirin Inc. supports clinical research in CTCL, with particular attention to mycosis fungoides and Sézary syndrome, including relapsed and refractory disease settings.
- Relapsed/refractory mycosis fungoides
- Sézary syndrome
- Cutaneous T-cell lymphoma
The sponsor’s activity in this area reflects interest in lymphoma subtypes that involve the skin and circulating malignant T cells.
Peripheral T-cell lymphoma and T-cell non-Hodgkin lymphoma
Its oncology portfolio also includes studies in aggressive T-cell lymphomas, covering both peripheral T-cell lymphoma and broader T-cell non-Hodgkin lymphoma indications.
- Peripheral T-cell lymphoma
- T-cell non-Hodgkin lymphoma
- Relapsed hematologic malignancy
This focus places the sponsor within the field of advanced hematologic cancer research.
Rare bone and mineral disorders
Kyowa Kirin Inc. is also active in X-linked hypophosphatemia, a rare inherited disorder affecting phosphate regulation and bone health.
- X-linked hypophosphatemia
- Phosphate metabolism
- Bone mineralization
Clinical interest in this area centers on the management of chronic skeletal and metabolic consequences of the disease.
Investigational biologics in oncology and rare disease
The sponsor’s clinical research includes evaluation of investigational agents such as mogamulizumab, KK8123, and KK2223 across hematologic malignancies and rare disease settings.
- Mogamulizumab
- KK8123
- KK2223
These programs span immunology-driven cancer care and disorders with limited treatment options.
